Physician profile
Jing Shen
NPI 1508908971
$6,419.67
in general payments reported to CMS, 2019-2025
30 companies · $951 in 2025
The $951 reported for 2025 was more than what 78% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,029 · 2020: $127 · 2021: $765 · 2022: $1,053 · 2023: $1,290 · 2024: $1,206 · 2025: $951.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,446.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,445.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $1,036.34 | 2021-2025 | |
| Optinose US, INC. | $938.11 | 2019-2025 | |
| Aerin Medical INC. | $865.15 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $758.54 | 2019-2025 | Dupixent |
| Glaxosmithkline, LLC. | $536.80 | 2022-2025 | Nucala, Trelegy Ellipta |
| Medtronic, INC. | $449.66 | 2022-2024 | Propel, Sinuva, Ligasure |
| Acclarent, INC | $375.75 | 2019-2023 | Trudi Nav Cable |
| Intersect Ent, INC. | $171.78 | 2019-2021 | |
| Ars Pharmaceuticals Operations, INC. | $163.93 | 2025 | Neffy |
| Stryker Corporation | $132.63 | 2019-2022 | |
| Arrinex, INC. | $131.44 | 2019 | |
| Cochlear Americas | $126.83 | 2022 | |
| Grifols USA, LLC | $124.99 | 2025 | Xembify |
| Alk-Abello, INC | $118.19 | 2021 | |
| Csl Behring | $71.75 | 2023-2025 | Hizentra |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $66.51 | 2024-2025 | Cuvitru, Takhzyro |
| Kaleo, INC. | $46.94 | 2022-2023 | Auvi-Q |
| Ambu INC. | $43.84 | 2020 | |
| Acera Surgical, INC. | $31.85 | 2024 | Restrata Wound Matrix |
| Paratek Pharmaceuticals, INC. | $27.69 | 2025 | Xhance |
| Blueprint Medicines Corporation | $26.39 | 2024 | Ayvakit |
| Hikma Pharmaceuticals USA | $24.99 | 2024 | Ryaltris |
| Phadia US INC. | $23.81 | 2024 | Immunocap |
| Amgen INC. | $23.12 | 2025 | Tavneos |
| Genentech USA, INC. | $21.70 | 2024 | Xolair |
| Integra Lifesciences Corporation | $20.19 | 2025 | Trudi Probe, Relieva Spinplus Nav, Inspira Air |
| Olympus America INC. | $17.79 | 2019 | |
| Heron Therapeutics, INC. | $16.08 | 2025 | Aponvie |
| Kowa Pharmaceuticals America, INC. | $14.47 | 2023 | Seglentis |
| Apria Healthcare LLC | $12.41 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jing Shen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.